[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (1,110)

Search Parameters:
Keywords = neutrophil-to-lymphocyte ratio

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
10 pages, 805 KiB  
Article
Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy
by Ezgi Değerli, Çağatay Arslan, Fatih Selçukbiricik, Ömer Fatih Ölmez, Dilek Erdem, Jamshid Hamdard, Mesut Yılmaz, Rumeysa Çolak, Caner Kapar, Mustafa Erman, Fatih Kuş and Deniz Tural
Medicina 2024, 60(12), 2103; https://doi.org/10.3390/medicina60122103 - 22 Dec 2024
Viewed by 217
Abstract
Background and Objectives: A high baseline neutrophil-to-lymphocyte ratio (NLR) is a poor prognostic factor in various cancers. However, its predictive role in metastatic bladder cancer (mBC) treated with immunotherapy is unclear. In this study, we aimed to investigate the relationship between the [...] Read more.
Background and Objectives: A high baseline neutrophil-to-lymphocyte ratio (NLR) is a poor prognostic factor in various cancers. However, its predictive role in metastatic bladder cancer (mBC) treated with immunotherapy is unclear. In this study, we aimed to investigate the relationship between the baseline and change in NLR and overall survival in mBC patients treated with immunotherapy, with the potential to significantly impact patient care. Materials and Methods: A retrospective analysis was conducted on 56 mBC patients who received second-line immunotherapy after progressing on platinum-based chemotherapy. Patients were classified into high and low NLR groups using a cutoff value of 3.3. A further division was made based on NLR changes after two cycles of immunotherapy: whether NLR increased (≥10%) or decreased (≥10%). The endpoint was to estimate the association between clinicopathological features and survival outcomes. Results: The study included 56 patients, with a median age of 66.6 years and a male-to-female ratio of 2.3:1. A low baseline NLR was associated with better OS than a high baseline NLR (p = 0.005). After two immunotherapy cycles, patients with a decreased NLR (≥10%) had significantly longer OS than those with an increased NLR (≥10%), regardless of the baseline NLR (p = 0.003). The overall median survival was 15 months, with 10 months for the NLR-increased group and not reached for the NLR-decreased group. Conclusions: Our study highlights the potential of baseline NLR and early changes in NLR as valuable prognostic markers for mBC patients receiving immunotherapy. Elevated neutrophils and lymphopenia negatively impact prognosis and treatment effectiveness, and NLR shows promise as a prognostic marker, inspiring further research and potential improvements in patient care. Full article
(This article belongs to the Section Oncology)
Show Figures

Figure 1

Figure 1
<p>Flowchart of the materials and methods.</p>
Full article ">Figure 2
<p>OS for baseline NLR.</p>
Full article ">Figure 3
<p>OS in the NLR decreasing and increasing groups.</p>
Full article ">
16 pages, 1837 KiB  
Article
Hemogram-Based Phenotypes of the Immune Response and Coagulopathy in Blunt Thoracic Trauma
by Alexandru Emil Băetu, Liliana Elena Mirea, Cristian Cobilinschi, Ioana Cristina Grințescu and Ioana Marina Grințescu
J. Pers. Med. 2024, 14(12), 1168; https://doi.org/10.3390/jpm14121168 - 21 Dec 2024
Viewed by 370
Abstract
Background: Blunt thoracic trauma possesses unique physiopathological traits due to the complex interaction of immune and coagulation systems in the lung tissue. Hemogram-based ratios such as neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte (PLR), neutrophil-to-lymphocyte × platelet (NLPR) ratios have been studied as proxies for immune [...] Read more.
Background: Blunt thoracic trauma possesses unique physiopathological traits due to the complex interaction of immune and coagulation systems in the lung tissue. Hemogram-based ratios such as neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte (PLR), neutrophil-to-lymphocyte × platelet (NLPR) ratios have been studied as proxies for immune dysregulation and survival in trauma. We hypothesized that blunt thoracic trauma patients exhibit distinct patterns of coagulation and inflammation abnormalities identifiable by the use of readily available hemogram-derived markers. Methods: The present study represents a retrospective observational analysis that included 86 patients with blunt thoracic trauma from a single high-volume level one trauma center. The primary outcome was mortality prediction in blunt thoracic trauma patients using these derived biomarkers. Secondary outcomes included phenotypes of the immune response and coagulopathy and the prediction of non-fatal adverse events. Results: A U-shaped distribution of mortality was found, with high rates of early deaths in patients with an NLPR value of <3.1 and high rates of late deaths in patients with NLPR > 9.5. A subgroup of blunt thoracic trauma patients expressing moderate inflammation and inflammation-induced hypercoagulation objectified as NLPR between 3.1 and 9.5 may have a survival benefit (p < 0.0001). The NLPR cut-off for predicting early deaths and the need for massive transfusion was 3.1 (sensitivity = 80.00% and specificity = 71.05%). Conclusions: These findings suggest that blunt thoracic trauma patients exhibit distinct phenotypes of the immune response and coagulopathy from the early stages. A controlled, balanced interaction of immune, coagulation, and fibrinolytic systems might effectively achieve tissue repair and increase survival in thoracic trauma patients and should be subject to further research. Full article
(This article belongs to the Special Issue Precision Medicine in the Intensive Care Unit)
Show Figures

Figure 1

Figure 1
<p>Flow diagram of patient enrollment.</p>
Full article ">Figure 2
<p>ROC curves of the NLPR for mortality prediction in thoracic trauma patients. CRP—C-reactive protein; NLR—neutrophil-to-lymphocyte ratio; PLR—platelet-to-lymphocyte ratio; NLPR—neutrophil-to-lymphocyte × platelet ratio.</p>
Full article ">Figure 3
<p>Estimation plot of the NLPR (survivors vs. non-survivors with an unpaired <span class="html-italic">t</span>-test).</p>
Full article ">Figure 4
<p>ROC curve of the NLPR for predicting early mortality and the need for massive transfusions in thoracic trauma patients.</p>
Full article ">Figure 5
<p>ROC curve of the NLPR for 30-day survival prediction in thoracic trauma patients.</p>
Full article ">Figure 6
<p>Survival curves of different phenotypes of inflammatory status based on the NLPR.</p>
Full article ">Figure 7
<p>U-shaped distribution of mortality at 30 days that is related to the inflammatory status based on the NLPR.</p>
Full article ">
13 pages, 691 KiB  
Article
Impact of Neutrophil-to-Lymphocyte Ratio on Stroke Severity and Clinical Outcome in Anterior Circulation Large Vessel Occlusion Stroke
by Zülfikar Memiş, Erdem Gürkaş, Atilla Özcan Özdemir, Bilgehan Atılgan Acar, Muhammed Nur Ögün, Emrah Aytaç, Çetin Kürşad Akpınar, Eşref Akıl, Murat Çabalar, Ayça Özkul, Ümit Görgülü, Hasan Bayındır, Zaur Mehdiyev, Şennur Delibaş Katı, Recep Baydemir, Ahmet Yabalak, Ayşenur Önalan, Türkan Acar, Özlem Aykaç, Zehra Uysal Kocabaş, Serhan Yıldırım, Hasan Doğan, Mehmet Semih Arı, Mustafa Çetiner, Ferhat Balgetir, Fettah Eren, Alper Eren, Nazım Kızıldağ, Utku Cenikli, Aysel Büşra Şişman Bayar, Ebru Temel, Alihan Abdullah Akbaş, Emine Saygın Uysal, Hamza Gültekin, Cebrail Durmaz, Sena Boncuk Ulaş and Talip Asiladd Show full author list remove Hide full author list
Diagnostics 2024, 14(24), 2880; https://doi.org/10.3390/diagnostics14242880 - 21 Dec 2024
Viewed by 278
Abstract
Background: The prognostic value of the neutrophil–lymphocyte ratio (NLR) in ischemic stroke remains debated due to cohort variability and treatment heterogeneity across studies. This study evaluates the relationship between admission NLR, stroke severity and 90-day outcomes in patients with anterior circulation large vessel [...] Read more.
Background: The prognostic value of the neutrophil–lymphocyte ratio (NLR) in ischemic stroke remains debated due to cohort variability and treatment heterogeneity across studies. This study evaluates the relationship between admission NLR, stroke severity and 90-day outcomes in patients with anterior circulation large vessel occlusion (LVO) undergoing early, successful revascularization. Methods: A retrospective multicenter study was conducted with 1082 patients treated with mechanical thrombectomy for acute ischemic stroke. The relationship between admission NLR, baseline National Institutes of Health Stroke Scale (NIHSS), 24 h NIHSS and 90-day modified Rankin Scale (mRS) outcomes was analyzed using logistic regression. Results: Admission NLR correlated weakly but significantly with both baseline (p = 0.018) and 24 h (p = 0.005) NIHSS scores, reflecting stroke severity. However, multivariate analysis showed that higher 24 h NIHSS scores (OR 0.831, p = 0.000) and prolonged puncture-to-recanalization times (OR 0.981, p = 0.000) were independent predictors of poor 90-day outcomes, whereas NLR was not (p = 0.557). Conclusions: Admission NLR is associated with stroke severity but does not independently predict clinical outcomes at 90 days in patients achieving early and successful revascularization. These findings underscore the critical role of inflammation in the acute phase of stroke but suggest that its prognostic value for long-term outcomes is limited in this context. Full article
Show Figures

Figure 1

Figure 1
<p>Patient selection flowchart.</p>
Full article ">Figure 2
<p>ROC curve for 24th hour NIHSS score predicting poor 90-day outcomes (AUC = 0.84, <span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">
11 pages, 1784 KiB  
Article
The Effects of Beta-Blockers on Leukocytes and the Leukocyte Subpopulation in Heart Failure Patients
by Anca Daniela Farcaş, Mirela Anca Stoia, Diana Larisa Mocan-Hognogi, Cerasela Mihaela Goidescu, Alexandra Florina Cocoi and Florin Petru Anton
Biomedicines 2024, 12(12), 2907; https://doi.org/10.3390/biomedicines12122907 - 20 Dec 2024
Viewed by 285
Abstract
Background/Objectives: Some specific types of white blood cells (WBCs) and the neutrophil/lymphocyte ratio (NLR) are independent predictors of outcome for heart failure (HF) patients. WBC redistribution is induced by catecholamines, and therefore we evaluate how different types of beta-blockers (BBs) influence it. Methods: [...] Read more.
Background/Objectives: Some specific types of white blood cells (WBCs) and the neutrophil/lymphocyte ratio (NLR) are independent predictors of outcome for heart failure (HF) patients. WBC redistribution is induced by catecholamines, and therefore we evaluate how different types of beta-blockers (BBs) influence it. Methods: The HF patients were clinically evaluated, and blood was drawn to measure N-Terminal pro–B-type natriuretic peptide (NT-proBNP), WBC-differential formula, etc. Results: On admission, 61.16% of patients who used a BB had no significant difference in the number of lymphocytes (Lym) and neutrophils (Neu), but NLR and NT- proBNP were significantly lower compared with those without BB. NT-proBNP correlated with BB dose on admission and was significantly lower in patients treated with Metoprolol (Met) as compared with Carvedilol (Car). The type and dose of BB used was responsible for 6.1% and 5.9% of the variability in the number of Lym and Neu, respectively. Patients treated with ≥100 mg Met/day had a higher Lym number, but not of Neu, with reduced NLR, compared with lower doses. Patients treated with ≥25 mg Car/day had a lower Lym number and a greater Neu number, compared with lower doses, with increased NLR. Conclusions: However, both BBs had the same rehospitalization rate during the 12 month follow-up and had an improved outcome. Full article
Show Figures

Figure 1

Figure 1
<p>Design of the study.</p>
Full article ">Figure 2
<p>The correlations between the levels of NT pro-BNP with metoprolol (higher doses reduce the level of NT proBNP more).</p>
Full article ">Figure 3
<p>The correlations between the levels of NT pro-BNP with carvedilol (higher doses reduce the level of NT proBNP more).</p>
Full article ">Figure 4
<p>Adrenergic governance of neutrophil functions in physiology and pathology. Use of β-blockers restores neutrophil functions in diseased states [<a href="#B33-biomedicines-12-02907" class="html-bibr">33</a>].</p>
Full article ">Figure 5
<p>Adrenergic signaling in cardiomyocytes and vasculature during adulthood (<b>A</b>,<b>C</b>) and aging (<b>B</b>,<b>D</b>) [<a href="#B34-biomedicines-12-02907" class="html-bibr">34</a>].</p>
Full article ">
15 pages, 1722 KiB  
Article
A Machine Learning-Based Model for Preoperative Assessment and Malignancy Prediction in Patients with Atypia of Undetermined Significance Thyroid Nodules
by Gilseong Moon, Jae Hyun Park, Taesic Lee and Jong Ho Yoon
J. Clin. Med. 2024, 13(24), 7769; https://doi.org/10.3390/jcm13247769 - 19 Dec 2024
Viewed by 275
Abstract
Objectives: The aim of this study was to investigate the preoperative clinical and hematologic variables, including the neutrophil-to-lymphocyte ratio (NLR), that can be used to predict malignancy in patients with atypia of undetermined significance (AUS) thyroid nodules; we further aimed to develop a [...] Read more.
Objectives: The aim of this study was to investigate the preoperative clinical and hematologic variables, including the neutrophil-to-lymphocyte ratio (NLR), that can be used to predict malignancy in patients with atypia of undetermined significance (AUS) thyroid nodules; we further aimed to develop a machine learning-based prediction model. Methods: We enrolled 280 patients who underwent surgery for AUS nodules at the Wonju Severance Christian Hospital between 2018 and 2022. A logistic regression-based model was trained and tested using cross-validation, with the performance evaluated using metrics such as the area under the receiver operating characteristic curve (AUROC). Results: Among the 280 patients, 116 (41.4%) were confirmed to have thyroid malignancies. Independent predictors of malignancy included age, tumor size, and the Korean Thyroid Imaging Reporting and Data System (K-TIRADS) classification, particularly in patients under 55 years of age. The addition of NLR to these predictors significantly improved the malignancy prediction accuracy in this subgroup. Conclusions: Incorporating NLR into preoperative assessments provides a cost-effective, accessible tool for refining surgical decision making in younger patients with AUS nodules. Full article
(This article belongs to the Special Issue Endocrine Malignancies: Current Surgical Therapeutic Approaches)
Show Figures

Figure 1

Figure 1
<p>Patient inclusion and exclusion criteria. AUS, atypia of undetermined significance; PTC, papillary thyroid carcinoma.</p>
Full article ">Figure 2
<p>Comparison of statistical significance across study subgroups for laboratory data. The degree of significance (<span class="html-italic">p</span>-values) of DNI, NLR, and PLR was evaluated using logistic regression analysis, including the binomial distribution of thyroid cancer and laboratory indices as dependent and independent variables, respectively. The logistic model was applied to the entire patient cohort, the older patient (≥55 years) group, and the younger (&lt;55 years) patient group, separately. The x-axis denotes the subgroup analysis according to different age groups. The y-axis indicates a negative log-transformed <span class="html-italic">p</span>-value evaluated using logistic regression. DNI, delta neutrophil index; NLR, neutrophil–lymphocyte ratio; PLR, platelet–lymphocyte ratio.</p>
Full article ">Figure 3
<p>Comparison of performance of four thyroid cancer prediction models (&lt;55 years old). Four classification models were established according to four different combinations of clinical biomarkers. The “base” model includes age, sex, primary tumor size, and K-TIRADS classification as the input variables. The “DNI” model integrates DNI alongside the variables in the base model. In the “NLR” model, NLR is included along with the base model variables. Similarly, the “PLR” model incorporates PLR together with the base model variables. An iteration of four-fold cross-validation was conducted 250 times on an original dataset obtained from the WSCH, yielding 1000 sample training datasets. Logistic regression was implemented to establish the classification model for the binomial distribution of thyroid malignancy status (thyroid cancer vs. benign nodule). The logistic model was iteratively run for the 1000 random training datasets, yielding 1000 performance values. The 1000 performance levels were obtained from the 1000 matched sampling testing datasets. A boxplot depicts the distribution of the 1000 performance measures. In Panel (<b>A</b>), different colors are used to visually distinguish between the four models (Base, DNI, NLR, PLR). These colors do not carry any specific quantitative meaning. In Panel (<b>B</b>), the colors in the matrix represent the magnitude of <span class="html-italic">p</span>-values, with deeper shades of red indicating smaller <span class="html-italic">p</span>-values. Gray cells represent <span class="html-italic">p</span>-values &gt;0.05, indicating no statistical significance. Exact <span class="html-italic">p</span>-values are displayed within each cell for clarity. K-TIRADS, Korean Thyroid Imaging Reporting and Data System; DNI, delta neutrophil index; NLR, neutrophil–lymphocyte ratio; PLR, platelet–lymphocyte ratio; WSCH, Wonju Severance Christian Hospital.</p>
Full article ">Figure 4
<p>Comparison of performance of four thyroid cancer prediction models (≥55 years old). Four classification models were devised utilizing different combinations of clinical biomarkers. The “base” model was constructed with age, sex, primary tumor size, and K-TIRADS classification as the input variables. The “DNI” model featured DNI in conjunction with the base model variables. The “NLR” model included NLR along with the base model variables, while the “PLR” model incorporated PLR together with the base model variables. An iterative process of four-fold cross-validation was conducted 250 times on an initial dataset sourced from the WSCH, resulting in the generation of 1000 training datasets through sampling. Logistic regression was employed to construct a classification model for the binomial distribution of thyroid malignancy status (thyroid cancer vs. benign nodule). The logistic model underwent iterative executions across the 1000 random training datasets, producing 1000 performance values. These performance levels were derived from 1000 corresponding testing datasets obtained through matched sampling. The distribution of the 1000 performance measures is visually represented in a boxplot. In Panel (<b>A</b>), different colors are used to visually distinguish between the four models (Base, DNI, NLR, PLR). These colors do not carry any specific quantitative meaning. In Panel (<b>B</b>), the colors in the matrix represent the magnitude of <span class="html-italic">p</span>-values, with deeper shades of red indicating smaller <span class="html-italic">p</span>-values. Gray cells represent <span class="html-italic">p</span>-values &gt;0.05, indicating no statistical significance. Exact <span class="html-italic">p</span>-values are displayed within each cell for clarity. K-TIRADS, Korean Thyroid Imaging Reporting and Data System; DNI, delta neutrophil index; NLR, neutrophil–lymphocyte ratio; PLR, platelet–lymphocyte ratio; WSCH, Wonju Severance Christian Hospital.</p>
Full article ">Figure 5
<p>Final malignancy prediction model. (<b>A</b>) Iteration of 4-fold cross-validation was applied 250 times to an original dataset obtained from the WSCH, yielding 1000 sample training datasets. Multivariate logistic regression was iteratively used for the 1000 random training sets to generate the binomial distribution of thyroid malignancy status (thyroid cancer vs. benign nodule), yielding 1000 beta coefficients per variable. (<b>B</b>) The equation for the thyroid cancer prediction model was established by computing the mean value of the 1000 parameters for each predictor. (<b>C</b>) AUROC was used to evaluate the classification performance for the dichotomous status of thyroid cancer condition. AUROC was measured using the 1000 testing datasets matched with the 1000 training sets obtained from the 250 × 4 CV. (<b>D</b>) The LR-based thyroid cancer index provides predictive values ranging from 0 to 1. Then, we selected the cut-off of the thyroid cancer index showing the maximum value of the F1 score. We employed 250 × 4 CV for the selection of the optimal predictive value of thyroid cancer, yielding 1000 cut-off values of the thyroid cancer index. The average of the 1000 cut-offs of the LR indices was identified as the optimal threshold for predicting thyroid cancer from AUS. K-TIRADS, Korean Thyroid Imaging Reporting and Data System; NLR, neutrophil–lymphocyte ratio; AUC, area under the curve; WSCH, Wonju Severance Christian Hospital; AUROC, area under the ROC curve; LR, logistic regression; CV, cross-validation; AUS, atypia of undetermined significance.</p>
Full article ">
13 pages, 446 KiB  
Article
Prognostic Value of Neutrophil, Monocyte, Lymphocyte, and Platelet/High-Density Lipoprotein Ratios in Ischemic Heart Disease: An NHANES Analysis
by Chia-Chen Wu, Chia-Hui Wu, Chien-Ho Lee, Tien-Yu Chen and Cheng-I Cheng
Medicina 2024, 60(12), 2084; https://doi.org/10.3390/medicina60122084 - 19 Dec 2024
Viewed by 272
Abstract
The prognostic value of easily accessible hematologic biomarkers, such as the neutrophil-to-HDL ratio, as well as the monocyte-to-HDL, lymphocyte-to-HDL, and platelet-to-HDL ratios, remains underexplored in patients with established ischemic heart disease (IHD). Community-dwelling adults aged ≥ 20 with established IHD from the National [...] Read more.
The prognostic value of easily accessible hematologic biomarkers, such as the neutrophil-to-HDL ratio, as well as the monocyte-to-HDL, lymphocyte-to-HDL, and platelet-to-HDL ratios, remains underexplored in patients with established ischemic heart disease (IHD). Community-dwelling adults aged ≥ 20 with established IHD from the National Health and Nutrition Examination Survey (NHANES) 1999–2018 were eligible. Mortality was tracked through linkage to the National Death Index (NDI) until the end of 2019. Cox regressions examined the associations between these hematologic ratios and all-cause mortality. Receiver operating characteristic (ROC) curve analysis assessed the predictive accuracy of these ratios for mortality. A total of 2265 patients were analyzed, with a median follow-up period of 80 months. After adjusting for demographic factors, lifestyle variables, and comorbidities, patients in the highest quartile of the neutrophil/HDL had a significantly increased all-cause mortality risk (aHR = 1.41, 95% CI: 1.13–1.77) compared to those in the lowest quartile. No significant associations were found between the other ratios and mortality. In conclusion, this study found that among the hematologic ratios analyzed, an elevated neutrophil-to-HDL ratio has the strongest potential for mortality risk stratification in community-dwelling patients with ischemic heart disease in the US, offering important guidance for both patients and clinicians. Full article
(This article belongs to the Section Cardiology)
12 pages, 4071 KiB  
Article
IL6 and IL6R as Prognostic Biomarkers in Colorectal Cancer
by Kathryn A. F. Pennel, Ahmad Kurniawan, Sara Samir Foad Al-Badran, Leonor Schubert Santana, Jean Quinn, Colin Nixon, Phimmada Hatthakarnkul, Noori Maka, Campbell Roxburgh, Donald McMillan and Joanne Edwards
Biomolecules 2024, 14(12), 1629; https://doi.org/10.3390/biom14121629 - 19 Dec 2024
Viewed by 496
Abstract
Colorectal cancer is the third most diagnosed malignancy worldwide and survival outcomes remain poor. Research is focused on the identification of novel prognostic and predictive biomarkers to improve clinical practice. There is robust evidence in the literature that inflammatory cytokine interleukin-6 (IL6) is [...] Read more.
Colorectal cancer is the third most diagnosed malignancy worldwide and survival outcomes remain poor. Research is focused on the identification of novel prognostic and predictive biomarkers to improve clinical practice. There is robust evidence in the literature that inflammatory cytokine interleukin-6 (IL6) is elevated systemically in CRC patients and that this phenomenon is a predictor of poor survival outcome. However, evidence is more limited for the role of IL6 and its cognate receptor, IL6R, within the tumour epithelium and microenvironment. This study aimed to investigate IL6 and IL6R expression in a large cohort of retrospectively collected patient tumour specimens and determine association with clinical outcomes and characteristics. High expression of IL6R in the tumour epithelium was associated with reduced cancer-specific survival in patients with right-sided colon cancer. In these patients, high IL6R expression was also associated with an increased systemic neutrophil-to-lymphocyte ratio. A high number of copies of IL6 mRNA within the tumour-associated stroma, but not epithelium, was associated with reduced cancer-specific survival. The results from this study have validated IL6R as a marker of poor prognosis in a subgroup of CRC patients and identified the spatially resolved prognostic nature of intra-tumoural IL6 expression. This study has also highlighted the need for investigation of IL6/IL6R-targeted therapies as novel treatment strategies for patients with colon cancer. Full article
Show Figures

Figure 1

Figure 1
<p>IL6R as a prognostic marker in colorectal cancer. Representative images showing a range of intensities of immunohistochemical staining for IL6R in colorectal cancer patient tissue (<b>A</b>). Kaplan Meier curve showing the association between cytoplasmic tumoural IL6R expression and cancer-specific survival in patient cohort 1 (<b>B</b>) and cohort 2 (<b>C</b>).</p>
Full article ">Figure 2
<p>IL6R as a prognostic marker in right-sided colon cancer. Box plot showing the distribution of weighted histoscores of cytoplasmic tumour IL6R across right-sided, left-sided and rectal cancers in patient cohort 1 (<b>A</b>). Kaplan Meier curve showing the association between cytoplasmic tumoural IL6R expression and cancer-specific survival in right-sided colon cancer cases from patient cohort 1 (<b>B</b>). Box plot showing the distribution of weighted histoscores of cytoplasmic tumour IL6R across right-sided, left-sided and rectal cancers in patient cohort 2 (<b>C</b>). Kaplan Meier curve showing the association between cytoplasmic tumoural IL6R expression and cancer-specific survival in right-sided colon cancer cases from patient cohort 2 (<b>D</b>).</p>
Full article ">Figure 3
<p>IL6 can be detected in the tumour epithelium and tumour-associated stroma of colorectal cancer patient specimens. Kaplan Meier curve showing the association between IL6 gene expression from RNA sequencing (<span class="html-italic">n</span> = 319) and cancer-specific survival in cohort 2 (<b>A</b>). Representative images showing colorectal cancer tissue from patient cohort 1 probed for IL6 mRNA via RNAScope<sup>®</sup> (<b>B</b>). Housekeeping control gene peptidyl-prolyl cis-trans isomerase B (PPIB) also shown (<b>B</b>). Box plot showing the quantification of IL6 in stromal and tumour compartments of patient cohort 1 analysed by the Mann–Whitney test (<b>C</b>). Box plot showing the quantification of IL6 in stromal and tumour compartments of a publicly available dataset using confoundR analysed by the Mann–Whitney test (<b>D</b>). Scatter plot for visualisation of the correlation between tumour and stromal IL6 in patient cohort 1 (<b>E</b>).</p>
Full article ">Figure 4
<p>IL6 as a prognostic marker in colorectal cancer. Kaplan Meier curves showing the association between stromal IL6 expression (<b>A</b>) and intra-tumoural IL6 expression (<b>B</b>) and cancer-specific survival in patient cohort 1.</p>
Full article ">
14 pages, 702 KiB  
Article
The Role of Inflammatory and Nutritional Indices in Postmenopausal Osteoporosis: A Retrospective Study
by Busra Demir Cendek, Burak Bayraktar, Mehmet Alican Sapmaz, Ayse Ecenaz Yıldırım, Mujde Can Ibanoglu and Yaprak Engin Ustun
J. Clin. Med. 2024, 13(24), 7741; https://doi.org/10.3390/jcm13247741 - 18 Dec 2024
Viewed by 309
Abstract
Background: Postmenopausal osteoporosis is characterized by impaired bone metabolism, inflammation, and nutritional deficiencies. This study aimed to evaluate the potential of inflammatory and nutritional markers in identifying decreased bone mineral density (BMD) in postmenopausal women. Methods: This cross-sectional study retrospectively analyzed [...] Read more.
Background: Postmenopausal osteoporosis is characterized by impaired bone metabolism, inflammation, and nutritional deficiencies. This study aimed to evaluate the potential of inflammatory and nutritional markers in identifying decreased bone mineral density (BMD) in postmenopausal women. Methods: This cross-sectional study retrospectively analyzed postmenopausal women from January 2018 and December 2023. A total of 368 women were divided into three groups based on T-scores: 61 women with osteoporosis (T-score ≤ −2.5), 153 women with osteopenia (−1 > T-score > −2.5), and 154 women with normal BMD (T-score > −1). Inflammatory and nutritional biomarkers included the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), pan-immune inflammation value (PIV), geriatric nutritional risk index (GNRI), triglycerides, total cholesterol, and body weight index (TCBI), prognosis nutritional index (PNI), hemoglobin, albumin, lymphocyte, and platelet (HALP) score, 25-OH Vitamin D level, Na, K, Ca, Mg, and their ratios. Results: The GNRI was significantly lower in the osteoporosis group compared to the control group. The NLR, PLR, SII, SIRI, PIV, TCBI, PNI, and HALP were similar between the groups. The GNRI and TCBI showed a positive correlation with T-scores. The Mg level was lower in the osteoporosis group than in the control group and osteopenia group, and the Na/Mg ratio was higher. Additionally, the Ca/Mg ratio was lower in the osteoporosis group than in the control group. The T-score was positively correlated with Mg and Ca/Mg, while the Na/Mg ratio showed a significant negative correlation. Vitamin D, other minerals, and their ratios did not show significant differences between the groups. Conclusions: Our findings suggest that the GNRI could serve as a useful indicator for assessing bone health and the risk of osteoporosis. Furthermore, maintaining appropriate levels of Mg and balanced Na/Mg and Ca/Mg ratios appears crucial for BMD. Full article
(This article belongs to the Section Obstetrics & Gynecology)
Show Figures

Figure 1

Figure 1
<p>Receiver operating characteristic (ROC) curves to evaluate the usefulness of age, duration of menopause, and Na/Mg in differentiating osteoporosis.</p>
Full article ">Figure 2
<p>Receiver operating characteristic (ROC) curves to evaluate usefulness of BMI, GNRI, Mg, and Ca/Mg in differentiating osteoporosis.</p>
Full article ">
13 pages, 286 KiB  
Article
Discordance Between Triglycerides, Remnant Cholesterol and Systemic Inflammation in Patients with Schizophrenia
by Jeffrey Wang, Maaike Kockx, Gabrielle J. Pennings, Tim Lambert, Vincent Chow and Leonard Kritharides
Biomedicines 2024, 12(12), 2884; https://doi.org/10.3390/biomedicines12122884 - 18 Dec 2024
Viewed by 318
Abstract
Background/Objectives: Hypertriglyceridaemia and systemic inflammation are prevalent in patients with schizophrenia and contribute to an increased risk of cardiovascular disease. Although elevated triglycerides (TGs) and remnant cholesterol are linked to inflammation in the general population and individuals with metabolic syndrome, whether they are [...] Read more.
Background/Objectives: Hypertriglyceridaemia and systemic inflammation are prevalent in patients with schizophrenia and contribute to an increased risk of cardiovascular disease. Although elevated triglycerides (TGs) and remnant cholesterol are linked to inflammation in the general population and individuals with metabolic syndrome, whether they are associated in patients with schizophrenia remains unclear. Methods: Fasting levels of TG, cholesterol (total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and remnant cholesterol)), and markers of systemic inflammation including high-sensitivity C-reactive protein (hsCRP), leukocyte counts and their differentials (neutrophils, monocytes and lymphocytes) were determined in 147 patients diagnosed with schizophrenia on long-term antipsychotic regimens and compared with 56 age- and sex-matched healthy controls. Apolipoprotein B and glycosylation of acute phase reactant (GlycA) signatures were assessed by NMR. Circulating cytokine levels were measured by a cytokine/chemokine multiplex assay. Results: Patients with schizophrenia had markedly elevated TG and remnant cholesterol relative to controls and had evidence of systemic inflammation with increased circulating hsCRP, GlycA, leukocyte, neutrophil counts and neutrophil-to-lymphocyte ratio (NLR). Unexpectedly TG and remnant cholesterol did not correlate with systemic inflammatory markers in patients with schizophrenia, and differences in inflammatory markers between controls and patients persisted after adjusting for the lipid profile. Interleukin (IL)-10 levels were increased in patients with schizophrenia, suggesting an anti-inflammatory signature. Conclusions: The discordance between TG, remnant cholesterol and systemic inflammation in patients with schizophrenia suggests these are likely independent contributors to cardiovascular risk in this population. Full article
(This article belongs to the Special Issue Advanced in Schizophrenia Research and Treatment)
15 pages, 2844 KiB  
Article
The Role of Complete Blood Count-Derived Inflammatory Biomarkers as Predictors of Infection After Acute Ischemic Stroke: A Single-Center Retrospective Study
by Weny Rinawati, Abdulloh Machin and Aryati Aryati
Medicina 2024, 60(12), 2076; https://doi.org/10.3390/medicina60122076 - 18 Dec 2024
Viewed by 297
Abstract
Background and Objectives: Although a wide range of hematological parameters are used as blood-based inflammatory biomarkers, the role of complete blood count-derived inflammatory biomarkers in infection after acute ischemic stroke (AIS) is modest. Therefore, this study aimed to explore complete blood count-derived [...] Read more.
Background and Objectives: Although a wide range of hematological parameters are used as blood-based inflammatory biomarkers, the role of complete blood count-derived inflammatory biomarkers in infection after acute ischemic stroke (AIS) is modest. Therefore, this study aimed to explore complete blood count-derived inflammatory biomarkers as predictors of infection after AIS. Materials and Methods: A single-center retrospective cross-sectional study was carried out at the National Brain Center Hospital Prof. Dr. dr. Mahar Mardjono, Jakarta, Indonesia, between 1 October 2023, and 31 March 2024, using medical records of hospitalized first-ever ischemic stroke patients who underwent a complete blood count within 24 h of admission. Based on complete blood count-derived inflammatory biomarkers, this study included absolute numbers and related ratios or indices. Results: In total, 163 patients met the study criteria. The diagnosis of infection after AIS was established using reliable clinical symptoms and/or guidelines of the disease. According to the status of infection after AIS, the subjects were categorized into two groups, including 24 patients in the infection group and 139 patients in the non-infection group. Biomarkers that had significant accuracy (higher sensitivity and specificity, respectively) in predicting infection were the leukocyte count (LC; 70.8%, 74.1%, p < 0.001), absolute neutrophil count (ANC; 66.7%, 79.9%, p < 0.001), absolute monocyte count (AMC; 75.0%, 63.3%, p = 0.001), neutrophil to lymphocyte ratio (NLR; 62.5%, 71.9%, p = 0.003), derivative NLR (dNLR; 50.0%, 78.4%, p = 0.003), monocyte–granulocyte to lymphocyte ratio (MGLR; 62.5%, 73.0%, p = 0.003), systemic inflammatory response index (SIRI; 62.5%, 79.0%, p = 0.001), and systemic immune inflammation index (SII; 87.5%, 44.0%, p = 0.012) with chances of 74.4%, 75.4%, 71.0%, 69.0%, 68.7%, 69.3%, 73.4%, and 66.2%, respectively. Conclusions: Considering the overall ROC curve used to evaluate the complete blood count-derived inflammatory biomarkers, ANC has a better ability to predict infection in AIS patients, as denoted by the highest AUC, suggesting a 75.4% chance of correctly discriminating patients with infection after stroke. Full article
(This article belongs to the Section Hematology and Immunology)
Show Figures

Figure 1

Figure 1
<p>Flowchart of study participants.</p>
Full article ">Figure 2
<p>The median leukocyte count (<span class="html-italic">p</span> &lt; 0.001) and platelet count (<span class="html-italic">p</span> = 0.592).</p>
Full article ">Figure 3
<p>The medians of leukocyte and platelet indices between the infection and non-infection AIS groups. ABC: absolute basophil count, AEC: absolute eosinophil count, ANC: absolute neutrophil count, ALC: absolute lymphocyte count, AMC: absolute monocyte count, BLR: basophil to lymphocyte ratio, ELR: eosinophil to lymphocyte ratio, NLR: neutrophil to lymphocyte ratio, dNLR: derivative NLR, MLR: monocyte to lymphocyte ratio, MGLR: monocyte–granulocyte to lymphocyte ratio, BMR: basophil to monocyte ratio, EMR: eosinophil to monocyte ratio, NMR: neutrophil to monocyte ratio, LMR: lymphocyte to monocyte ratio, BPR: basophil to platelet ratio, MPR: monocyte to platelet ratio, PNR: platelet to neutrophil ratio, PLR: platelet to lymphocyte ratio, SIRI: systemic inflammatory response index, SII: systemic immune inflammation index.</p>
Full article ">Figure 4
<p>Receiver operating characteristic (ROC) curves of complete blood count-derived inflammatory biomarkers: (<b>A</b>) Leukocyte and platelet count, (<b>B</b>) Absolute leukocyte differential count, (<b>C</b>) Ratio to lymphocytes, (<b>D</b>) Ratio to monocytes, (<b>E</b>) Ratio to platelets, (<b>F</b>) Ratio of platelets to neutrophils and lymphocytes, and (<b>G</b>) Systemic inflammatory index.</p>
Full article ">
13 pages, 1292 KiB  
Article
Evaluating the Role of CBC-Derived Indices in Children with Hashimoto’s Thyroiditis
by Andrei-Ioan Munteanu, Iulius Jugănaru, Delia-Maria Nicoară, Niculina Mang, Raluca Vasilescu, Giorgiana-Flavia Brad, Alexandra-Cristina Scutca, Raluca Asproniu, Lucian-Ioan Cristun and Otilia Mărginean
Diagnostics 2024, 14(24), 2834; https://doi.org/10.3390/diagnostics14242834 - 17 Dec 2024
Viewed by 358
Abstract
Background/Objectives: Hashimoto’s thyroiditis (HT) is an autoimmune disorder characterized by chronic inflammation of the thyroid gland. Recent evidence indicates that the inflammation may extend beyond the thyroid. The study aims to explore the potential of complete blood count (CBC)-derived indices as markers of [...] Read more.
Background/Objectives: Hashimoto’s thyroiditis (HT) is an autoimmune disorder characterized by chronic inflammation of the thyroid gland. Recent evidence indicates that the inflammation may extend beyond the thyroid. The study aims to explore the potential of complete blood count (CBC)-derived indices as markers of systemic inflammation in HT. Materials and Methods: This cross-sectional retrospective study from 1 January 2015, to 31 December 2023 included 147 pediatric HT patients and 144 apparently healthy controls. Thyroid profiles, antibodies, CBC, and protein electrophoresis data were collected from patient records. CBC-derived indices were calculated and compared between the HT and control groups, as well as among HT subgroups. Results: The median age of HT patients was 13.6 years (range: 11.2–15.5 years), with 66% being girls. The control group had a similar age and gender distribution, with a median age of 13.7 years (range: 11–15.8 years) and 70.8% girls. Of the HT patients, 50% had subclinical HT, 15% were euthyroid, and 34% had overt thyroid dysfunction. HT patients showed significantly higher neutrophil and lymphocyte counts, as well as all evaluated CBC-derived indices than controls (p < 0.001)). These differences were not significant among HT subgroups. Logistic regression indicated a strong association between an elevated neutrophil-to-lymphocyte ratio (NLR) and HT diagnosis (p < 0.001), while ROC analysis confirmed NLR as the most accurate CBC-derived marker for distinguishing HT from controls. Conclusions: Elevated NLR levels in pediatric HT patients provide additional evidence that inflammation may extend beyond the thyroid gland. These results support the potential of NLR as a reliable and accessible biomarker for evaluating inflammation in Hashimoto’s thyroiditis. Full article
Show Figures

Figure 1

Figure 1
<p>Schematic representation of the HT patient selection process. T1DM, type 1 diabetes mellitus; LES, systemic lupus erythematosus; JIA, juvenile idiopathic arthritis; GN, glomerulonephritis.</p>
Full article ">Figure 2
<p>Correlation between CBC parameters and indices and HT diagnosis. HT, Hashimoto’s thyroiditis; NLR, neutrophil/lymphocyte ratio; PLR, platelet/lymphocyte ratio; SII, systemic inflammation index; SIRI, systemic inflammation response index. The significance levels were marked as *** <span class="html-italic">p</span> &lt; 0.001, ** <span class="html-italic">p</span> &lt; 0.01, and * <span class="html-italic">p</span> &lt; 0.05. The accompanying figure employs a color gradient to depict significance levels, with darker shades representing more substantial associations and lighter shades indicating lesser degrees of statistical significance.</p>
Full article ">Figure 3
<p>Receiver operating characteristic curve analysis for evaluating the performance of (<b>a</b>) NLR, (<b>b</b>) PLR, (<b>c</b>) SII, and (<b>d</b>) SIRI in discriminating HT patients from controls.</p>
Full article ">
14 pages, 867 KiB  
Article
Peripheral Circulating Blood Cells Deviation Based on Tumor Inflammatory Microenvironment Activity in Resected Upstaged Lung Adenocarcinomas
by Alessandro Bonis, Francesca Lunardi, Giulia Pagliarini, Vincenzo Verzeletti, Luigi Lione, Alberto Busetto, Giorgio Cannone, Giovanni Maria Comacchio, Marco Mammana, Eleonora Faccioli, Alessandro Rebusso, Marco Schiavon, Samuele Nicotra, Andrea Dell’Amore and Federico Rea
J. Clin. Med. 2024, 13(24), 7597; https://doi.org/10.3390/jcm13247597 - 13 Dec 2024
Viewed by 328
Abstract
Background: The tumour inflammatory microenvironment (TIME) reflects a selective activation of the central immune system (IS), particularly T-cells expansion, which leads to immune cells migrating to the target, such as lung cancer, via the bloodstream and lymphatic vessels. In this study, the [...] Read more.
Background: The tumour inflammatory microenvironment (TIME) reflects a selective activation of the central immune system (IS), particularly T-cells expansion, which leads to immune cells migrating to the target, such as lung cancer, via the bloodstream and lymphatic vessels. In this study, the aim is to investigate whether the distribution of peripheral blood cells varies based on the immune status of patients with lung adenocarcinoma. Methods: This is a single-center retrospective study conducted in the Thoracic Surgery Unit of the University of Padua (Italy) between 1 January 2016 and 1 April 2024. It included patients (>18 years old) with lung adenocarcinoma deemed resectable (cT2bN0M0 or lower) who experienced pathological upstaging (IIB or higher). Patients were classified as TIME-active (with tumour-infiltrating lymphocytes—TILs and/or PD-L1 expression) or TIME-silent (without TILs or PD-L1). According to the TIME status, peripheral blood cell counts with clinical and pathological data were compared between groups using the Fisher’s, Pearson’s or Wilcoxon’s test when appropriate. A Kaplan–Meier estimator investigated overall survival (OS) and recurrence-free survival (RFS) adopting the log-rank test. Results: Preoperatively, the TIME-a group demonstrated a significantly higher lymphocyte count (p = 0.02) and a lower absolute neutrophil rate (p = 0.01) than TIME-s. These differences persisted after resection (p = 0.06 and p = 0.02) while they became similar one month after surgery (p = 1 and p = 0.32). The neutrophil-to-lymphocyte ratio—NLR showed similar trends (p = 0.01 and p = 1). Better OS and RFS were shown in the TIME-a group (p = 0.02 and 0.03, respectively). Conclusions: Resected upstaged lung adenocarcinomas show distinct peripheral blood cell profiles based on immune status. TIME-active patients had a significantly lower NLR, which normalized post-surgery. Surgical resection may help restore native immune surveillance. Full article
(This article belongs to the Section Oncology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Preoperative values of peripheral circulating white blood cells. (<b>A</b>) WBC comparison between TIME-a and TIME-s; (<b>B</b>) PMN comparison between TIME-a and TIME-s; (<b>C</b>) Lymphocytes comparison between TIME-a and TIME-s; (<b>D</b>) Monocytes comparison between TIME-a and TIME-s.</p>
Full article ">Figure 2
<p>Postoperative values of peripheral circulating white blood cells. Differences seemed to be leveled one month after surgery, at the oncological evaluation before starting any adjuvant therapy. (<b>A</b>) WBC comparison between TIME-a and TIME-s; (<b>B</b>) PMN comparison between TIME-a and TIME-s; (<b>C</b>) Lymphocytes comparison between TIME-a and TIME-s; (<b>D</b>) Monocytes comparison between TIME-a and TIME-s.</p>
Full article ">Figure 3
<p>Neutrophil-to-lymphocyte ratio according to the immune status of patients, divided into preoperative (<b>A</b>) and postoperative (<b>B</b>) ratio.</p>
Full article ">Figure 4
<p>(<b>A</b>) Overall survival between the two groups; (<b>B</b>) recurrence-free survival comparison.</p>
Full article ">
12 pages, 790 KiB  
Article
Does the LDH/Albumin Ratio Bring Novelty? A Comparative Analysis with Inflammatory Indices and Combined Models in Adult-Onset Still’s Disease
by Ali Ekin, Salim Mısırcı, Hikmet Öztop, Asuman Şebnem Hacımustafaoğlu, Belkıs Nihan Coşkun, Burcu Yağız, Ediz Dalkılıç and Yavuz Pehlivan
Diagnostics 2024, 14(24), 2780; https://doi.org/10.3390/diagnostics14242780 - 11 Dec 2024
Viewed by 373
Abstract
Background/Objectives: The objective of this study was to evaluate the diagnostic accuracy of the lactate dehydrogenase-to-albumin ratio (LAR) in adult-onset Still’s disease (AOSD) and compare it with other inflammatory indices, using patients with fever of unknown origin (FUO) as a control group due [...] Read more.
Background/Objectives: The objective of this study was to evaluate the diagnostic accuracy of the lactate dehydrogenase-to-albumin ratio (LAR) in adult-onset Still’s disease (AOSD) and compare it with other inflammatory indices, using patients with fever of unknown origin (FUO) as a control group due to their overlapping clinical features with AOSD. The study also compared LAR’s diagnostic performance with other inflammatory indices like the serum immune-inflammatory index (SII), ferritin/erythrocyte sedimentation rate (FER), CRP/albumin ratio (CAR), platelet/lymphocyte ratio (PLR), and neutrophil/lymphocyte ratio (NLR), as well as its combinations with FER, PLR, and ferritin (LAR + FER, LAR + PLR, LAR + ferritin). Methods: A retrospective evaluation was conducted on 70 patients with fever of unknown cause and 78 patients with AOSD, admitted between January 2000 and December 2023 in a tertiary care hospital. Demographic, clinical, and laboratory characteristics were compared between the groups. ROC analysis provided cutoff values, sensitivity, and specificity for each inflammatory index. Results: ROC analysis showed significant p-values (p < 0.05) for indices other than LAR (p = 0.090) LAR + PLR (p = 0.806), and PLR (p = 0.634) in diagnosing AOSD. The highest specificity was found in LAR + ferritin (92.90%), and the highest sensitivity in CAR (100.0%). NLR, SII, FER, and LAR + FER were the indices with both sensitivity and specificity above 50%. LAR had a sensitivity of 76.90% and a specificity of 48.60%. The cutoff values were 3978.0 µg/L for ferritin and 70.98 for LAR. Significant statistical differences between AOSD and non-AOSD groups were observed for all indices except CAR (p = 0.133). Conclusions: LAR can differentiate AOSD patients from FUO, but its specificity is lower than most other indices. The diagnostic utility of these indices in clinical practice remains controversial. Full article
Show Figures

Figure 1

Figure 1
<p>Flowchart for study.</p>
Full article ">Figure 2
<p>Receiver operating characteristic (ROC) curves pertaining to the diagnostic utility inflammation indices and markers for adult-onset Still’s disease (AOSD) patients. (<b>A</b>) For an AOSD diagnosis, the area under the curve (AUC) was 0.581 (95% CI, 0.485–0.676) for LDH-to-albumin ratio (LAR), 0.609 (95% CI, 0.517–0.701) for neutrophil-to-lymphocyte ratio (NLR), 0.657 (95% CI, 0.569–0.744) for Systemic immune-inflammation index (SII), 0.732 (95% CI, 0.653–0.811) for ferritin. (<b>B</b>) For an AOSD diagnosis, the AUC was 0.477 (95% CI, 0.381–0.574) for platelet-to-lymphocyte ratio (PLR), 0.317 (95% CI, 0.230–0.404) for C-reactive protein/albumin ratio (CAR), 0.737 (95% CI, 0.657–0.817) for ferritin-to-erythrocyte sedimentation rate ratio (FER). (<b>C</b>) For an AOSD diagnosis, the AUC was 0.581 (95% CI, 0.485–0.676) for LAR, 0.488 (95% CI, 0.393–0.584) for LAR + PLR, 0.696 (95% CI, 0.609–0.783) for LAR + FER and, 0.729 (95% CI, 0.649–0.808) for LAR + ferritin.</p>
Full article ">
14 pages, 3597 KiB  
Article
The Importance of the Neutrophil–Lymphocyte Ratio (NLR) and the Platelet–Lymphocyte Ratio (PLR) as Biomarkers for Differentiating Complicated and Uncomplicated Appendicitis
by Michail Anastasakis, Ioannis Trevlias, Konstantinos Farmakis and Ioannis Valioulis
Diagnostics 2024, 14(24), 2777; https://doi.org/10.3390/diagnostics14242777 - 11 Dec 2024
Viewed by 376
Abstract
Background: This specific study evaluates the accuracy of two ratios, Neutrophil-to-Lymphocyte (N/L) and Platelet-to-Lymphocyte (P/L), as inflammatory markers on differentiating simple and complicated appendicitis preoperatively. Methods: The medical records of 341 children, up to 16 years old, with suspected acute appendicitis (AA) who [...] Read more.
Background: This specific study evaluates the accuracy of two ratios, Neutrophil-to-Lymphocyte (N/L) and Platelet-to-Lymphocyte (P/L), as inflammatory markers on differentiating simple and complicated appendicitis preoperatively. Methods: The medical records of 341 children, up to 16 years old, with suspected acute appendicitis (AA) who underwent appendectomy, laparoscopic or open, between January 2020 and December 2022, in our department, were retrospectively reviewed. Routine blood exams and the demographic details were obtained. The area under the curve (AUC), sensitivity, and specificity of the above-mentioned markers regarding the differentiation of simple and complicated appendicitis, based on the statistical program SPSS, were calculated. Results: From the total of 341 patients, a percentage of 27.5% were related to perforated appendicitis, such as necrosis or the rupture of the appendiceal wall. A significant association was observed between perforated appendicitis and NLR values > 7.92, with concomitant sensitivity 62.5% and specificity 74.2%. Retrospectively, for PLR values > 180.57, the sensitivity was 61.1% and specificity 68.9%. For these models, the areas under the curve were 0.736 and 0.696. Conclusions: Our study revealed a significant association of N/L and P/L ratios with acute perforated appendicitis. Future studies should validate the use of these markers on this disease. Full article
(This article belongs to the Special Issue Diagnosis and Treatment of Pediatric Emergencies—2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Variation of the NLR according to the phase of inflammation.</p>
Full article ">Figure 2
<p>Variation of the NLR according to the phase of inflammation. (*, o: These symbols refer to patients who deviate from standard values).</p>
Full article ">Figure 3
<p>Variation of the PLR according to the phase of inflammation.</p>
Full article ">Figure 4
<p>Variation of the PLR according to the phase of inflammation. (*, o: These symbols refer to patients who deviate from standard values).</p>
Full article ">Figure 5
<p>ROC curve for the entire sample of the study.</p>
Full article ">Figure 6
<p>ROC model quality for the entire sample.</p>
Full article ">Figure 7
<p>Correlation of two parameters of the study in a linear curve.</p>
Full article ">Figure 8
<p>ROC curve by gender.</p>
Full article ">Figure 9
<p>ROC model quality by gender.</p>
Full article ">Figure 10
<p>ROC curve by age group.</p>
Full article ">Figure 11
<p>ROC model quality by age group.</p>
Full article ">
10 pages, 223 KiB  
Article
Can Neutrophil-to-Lymphocyte Ratio, Platelet Volume, and Platelet Distribution Width Be Used as Indicators of Delirium?
by Bilge Tuncer, Fulya Çelik, Burak Çelik and Ezgi Erkılıç
J. Clin. Med. 2024, 13(24), 7532; https://doi.org/10.3390/jcm13247532 - 11 Dec 2024
Viewed by 312
Abstract
Background/Objectives: Postoperative delirium is a frequent complication in children undergoing general anesthesia. It has been suggested that inflammation and oxidative stress contribute to the pathophysiology of delirium. The aim of our study was to investigate the relationship between inflammatory markers and delirium. Methods: [...] Read more.
Background/Objectives: Postoperative delirium is a frequent complication in children undergoing general anesthesia. It has been suggested that inflammation and oxidative stress contribute to the pathophysiology of delirium. The aim of our study was to investigate the relationship between inflammatory markers and delirium. Methods: A total of 221 children in the ASA 1–3 risk group who underwent adenoidectomy, tonsillectomy, and/or ventilation tube application were included in our single-center, prospective, and observational study approved by the Ethics Committee, numbered E1-23-3197. Patients whose parental consent was obtained were either premedicated with oral midazolam preoperatively or taken to surgery without premedication, depending on the anesthesiologist’s preference. After induction with sevoflurane, rocuronium and fentanyl were administered intravenously. Sevoflurane and infusion of remifentanil were administered for maintenance. At the end of the operation, patients were transferred to the recovery unit and followed up for 30 min. They were evaluated with the Face, Legs, Activity, Cry, and Consolability (FLACC) Scale and Pediatric Anesthesia Emergence Delirium (PAED) Scale. Results: Delirium was observed in 80 patients. There was no significant difference between patients with and without delirium in terms of neutrophil/lymphocyte ratio, mean platelet volume, or platelet distribution volume. Lymphocyte count, PAED score, and FLACC score were statistically higher in patients with delirium (W = 4407.5, p-value = 0.006997; W = 0, p-value < 2.2 × 10−16; W = 9489, p-value < 2.2 × 10−16, respectively). Conclusions: No statistically significant relationship was found between hematologic inflammatory markers and delirium. Controlled studies with larger sample sizes are needed to determine whether these markers have strong predictive value. Full article
(This article belongs to the Section Hematology)
Back to TopTop